Galway Metals (GWM) Analysts See $-0.01 EPS; Aqr Capital Management Lowered Ligand Pharmaceuticals (LGND) Position

August 11, 2017 - By Dolores Ford

Aqr Capital Management Llc decreased Ligand Pharmaceuticals Inc (LGND) stake by 70.26% reported in 2016Q4 SEC filing. Aqr Capital Management Llc sold 18,310 shares as Ligand Pharmaceuticals Inc (LGND)’s stock rose 7.66%. The Aqr Capital Management Llc holds 7,750 shares with $787,000 value, down from 26,060 last quarter. Ligand Pharmaceuticals Inc now has $2.62B valuation. The stock decreased 1.57% or $1.99 during the last trading session, reaching $124.98. About shares traded. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has declined 2.87% since August 11, 2016 and is downtrending. It has underperformed by 19.57% the S&P500.

Analysts expect Galway Metals Inc (CVE:GWM) to report $-0.01 EPS on September, 4.After having $-0.03 EPS previously, Galway Metals Inc’s analysts see -66.67% EPS growth. The stock increased 1.43% or $0.005 on August 10, reaching $0.355. About 10,100 shares traded. Galway Metals Inc (CVE:GWM) has 0.00% since August 11, 2016 and is . It has underperformed by 16.70% the S&P500.

Galway Metals Inc. is an exploration-stage company. The company has market cap of $21.08 million. The Firm operates through the acquisition, exploration and development of mineral resource properties in the United States segment. It currently has negative earnings. The Company’s projects include Clarence Stream Project, Estrades and Casa Berardi Break.

Aqr Capital Management Llc increased Saia Inc (NASDAQ:SAIA) stake by 16,695 shares to 25,330 valued at $1.12 million in 2016Q4. It also upped First Busey Corp stake by 41,671 shares and now owns 106,808 shares. Intl Paper Co (NYSE:IP) was raised too.

Among 5 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Ligand Pharmaceuticals had 15 analyst reports since September 3, 2015 according to SRatingsIntel. The rating was maintained by Roth Capital on Wednesday, September 30 with “Buy”. On Thursday, November 19 the stock rating was maintained by Roth Capital with “Buy”. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Thursday, September 3. The firm earned “Buy” rating on Wednesday, September 30 by TH Capital. The firm has “Buy” rating given on Friday, December 18 by TH Capital. As per Friday, August 5, the company rating was downgraded by Deutsche Bank. TH Capital maintained it with “Buy” rating and $144 target in Thursday, November 19 report. On Tuesday, August 8 the stock rating was maintained by Deutsche Bank with “Hold”. Stephens initiated Ligand Pharmaceuticals Inc. (NASDAQ:LGND) rating on Wednesday, April 13. Stephens has “Overweight” rating and $150 target. The rating was maintained by Roth Capital on Friday, March 11 with “Buy”.

Since February 27, 2017, it had 0 buys, and 7 insider sales for $11.11 million activity. On Monday, March 20 the insider HIGGINS JOHN L sold $436,400. $630,650 worth of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was sold by FOEHR MATTHEW W on Friday, May 12. The insider Aryeh Jason sold $4.13 million.

Investors sentiment increased to 1.2 in Q4 2016. Its up 0.12, from 1.08 in 2016Q3. It increased, as 23 investors sold LGND shares while 85 reduced holdings. 39 funds opened positions while 91 raised stakes. 22.77 million shares or 1.00% less from 23.00 million shares in 2016Q3 were reported. Howe & Rusling Inc reported 1,335 shares. Dimensional Fund Advisors Lp owns 268,333 shares or 0.01% of their US portfolio. Virginia Retirement Et Al invested in 14,200 shares. Profund Advisors Limited Liability Company holds 11,245 shares. Gotham Asset Mgmt Limited Liability Corp has 33,965 shares. Falcon Point Cap holds 2.24% or 164,246 shares in its portfolio. Pictet Asset Mgmt reported 0.01% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Moreover, 1492 Mgmt Ltd Limited Liability Company has 0.79% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). State Of Tennessee Treasury Department owns 0.01% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 15,123 shares. Bb&T stated it has 3,058 shares. Gideon Advsr owns 3,787 shares. Fisher Asset Management Ltd Llc reported 0.01% stake. Alpine Woods Cap Invsts Lc reported 0.02% stake. Colony, a Massachusetts-based fund reported 22,589 shares. 500 are owned by Wealthtrust.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :